Patent ID: 9611245
Date: 2017-04-04
CPC Classifications: A61K,A61P,C07D

Claim:
1. A compound of Formula (I) or a pharmaceutically acceptable salt or solvate thereof: wherein Ar and Ar′ are independently selected from the group consisting of a 5- to 10-membered aromatic and heteroaromatic single or fused rings comprising up to 3 heteroatoms selected from N, O and S; R is selected from the group consisting of hydrogen, a linear or branched unsubstituted or substituted C R Y is selected from the group consisting of N and CH; X is selected from the group consisting of CH and N; R R or R q and p are, independently, 0 or an integer from 1 to 2 with the proviso that when both Y and X are N, neither q and p are 0; R W is selected from the group consisting of a bond and a heteroatom selected from the group consisting of O, S and NR m is an integer from 1 to 3, n is 0 or an integer from 1 to 3 with the proviso that when W is bond, n is not 0; provided that the compound of Formula (I) is not: 4-[[[1-(4-methoxyphenyl)cyclopentyl]amino]methyl]-2-[(4-methyl-1-piperazinyl)methyl]-phenol; 4-[[[1-(2-fluorophenyl)cyclopentyl]amino]methyl]-2-[(4-methyl-1-piperazinyl)methyl]-phenol or 4-[[[1-(2-methoxyphenyl)cyclopentyl]amino]methyl]-2-[(4-methyl-1-piperazinyl)methyl]-phenol.